Emerging infectious diseases (EIDs) represent an ongoing threat to blood safety. Therefore
it is important that blood centres perform risk assessments for EID agents to inform decisions …

Tra le proteine codificate da HIV-1, Tat sembrerebbe essere responsabile della regolazione
dei linfociti B del centro germinativo mediante l'attivazione costitutiva del fattore NF-kB …

Immunoglobulins (IgG) derived from the human plasma are used as biotherapeutics
primarily in the form of polyclonal IgG or as hyperimmune sera. Intravenous Immunoglobulin …

Le dépistage des infections transmissibles par la transfusion joue un rôle essentiel au sein
de tout programme national de transfusion sanguine. Toutefois, il convient néanmoins de …

Human leishmaniasis is a vector-borne diseases, caused by the Leishmania parasite and
endemic in 100 countries, including southern Europe. The clinical spectrum of Leishmania …

Abstract Human Immunodeficiency Virus-1 (HIV-1) is a retrovirus that was identified more
than thirty years ago as the cause of Acquired Immunodeficiency Syndrome (AIDS). The only …

Vonicog alfa (VONVENDI), a human recombinant form of von Willebrand factor (rVWF), is a
valuable addition to the treatments available to treat bleeding episodes in adults with von …

The mission of Edinburgh Infectious Diseases is to build a world leading consortium in
infectious disease sciences across the University of Edinburgh and neighbouring Institutions …

A blood transfusion is a common treatment for a range of conditions. Over 112 million blood
transfusions are administered each year worldwide and many patients are thereby exposed …